Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection
書誌事項
- 公開日
- 2021-08
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- https://doi.org/10.15223/policy-017
- https://doi.org/10.15223/policy-037
- https://doi.org/10.15223/policy-012
- https://doi.org/10.15223/policy-029
- https://doi.org/10.15223/policy-004
- DOI
-
- 10.1016/j.coviro.2021.04.006
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Current Opinion in Virology
-
Current Opinion in Virology 49 36-40, 2021-08
Elsevier BV
